Literature DB >> 26830052

blaCTX-M-15 carried by IncF-type plasmids is the dominant ESBL gene in Escherichia coli and Klebsiella pneumoniae at a hospital in Ghana.

Alex Agyekum1, Alicia Fajardo-Lubián2, Daniel Ansong3, Sally R Partridge2, Tsiri Agbenyega3, Jonathan R Iredell4.   

Abstract

Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases (ESBLs) are among the most multidrug-resistant pathogens in hospitals and are spreading worldwide. Horizontal gene transfer and spread of high-risk clones are involved in ESBL dissemination. Investigation of the resistance phenotypes of 101 consecutive clinical E. coli (n=58) and K. pneumoniae (n=43) isolated at the Komfo Anokye Teaching Hospital in Ghana over 3 months revealed 63 (62%) with an ESBL phenotype. All 63 had a blaCTX-M gene, and sequence analysis showed that 62 of these were blaCTX-M-15. blaCTX-M-15 was linked to ISEcp1 and orf477Δ in all isolates, and most isolates also carried blaTEM, aac(3)-II, aacA4cr, and/or blaOXA-30 genes on IncF plasmids. XbaI/pulsed-field electrophoresis showed heterogeneity among isolates of both species, suggesting that blaCTX-M-15 dissemination is caused by horizontal gene transfer rather than clonal spread of these species in Ghana. Crown
Copyright © 2016. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; CTX-M enzymes; ESBLs; Enterobacteriaceae; Ghana; PFGE

Mesh:

Substances:

Year:  2015        PMID: 26830052     DOI: 10.1016/j.diagmicrobio.2015.12.010

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  10 in total

1.  Predictability of Phenotype in Relation to Common β-Lactam Resistance Mechanisms in Escherichia coli and Klebsiella pneumoniae.

Authors:  Alex Agyekum; Alicia Fajardo-Lubián; Xiaoman Ai; Andrew N Ginn; Zhiyong Zong; Xuejun Guo; John Turnidge; Sally R Partridge; Jonathan R Iredell
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

2.  Diarrhoeagenic E. coli occurrence and antimicrobial resistance of Extended Spectrum Beta-Lactamases isolated from diarrhoea patients attending health facilities in Accra, Ghana.

Authors:  Helena Dela; Beverly Egyir; Ayodele O Majekodunmi; Eric Behene; Clara Yeboah; Dominic Ackah; Richard N A Bongo; Bassirou Bonfoh; Jakob Zinsstag; Langbong Bimi; Kennedy Kwasi Addo
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

3.  Very high prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in bacteriemic patients hospitalized in teaching hospitals in Bamako, Mali.

Authors:  Samba Adama Sangare; Emilie Rondinaud; Naouale Maataoui; Almoustapha Issiaka Maiga; Ibrehima Guindo; Aminata Maiga; Namory Camara; Oumar Agaly Dicko; Sounkalo Dao; Souleymane Diallo; Flabou Bougoudogo; Antoine Andremont; Ibrahim Izetiegouma Maiga; Laurence Armand-Lefevre
Journal:  PLoS One       Date:  2017-02-28       Impact factor: 3.240

4.  Household cockroaches carry CTX-M-15-, OXA-48- and NDM-1-producing enterobacteria, and share beta-lactam resistance determinants with humans.

Authors:  Noah Obeng-Nkrumah; Appiah-Korang Labi; Harriet Blankson; Georgina Awuah-Mensah; Daniel Oduro-Mensah; Judelove Anum; James Teye; Solomon Dzidzornu Kwashie; Evariste Bako; Patrick Ferdinand Ayeh-Kumi; Richard Asmah
Journal:  BMC Microbiol       Date:  2019-12-04       Impact factor: 3.605

5.  Genomic network analysis of environmental and livestock F-type plasmid populations.

Authors:  A Sarah Walker; Nicole Stoesser; Liam P Shaw; William Matlock; Kevin K Chau; Manal AbuOun; Emma Stubberfield; Leanne Barker; James Kavanagh; Hayleah Pickford; Daniel Gilson; Richard P Smith; H Soon Gweon; Sarah J Hoosdally; Jeremy Swann; Robert Sebra; Mark J Bailey; Timothy E A Peto; Derrick W Crook; Muna F Anjum; Daniel S Read
Journal:  ISME J       Date:  2021-03-01       Impact factor: 11.217

6.  Clones and Clusters of Antimicrobial-Resistant Klebsiella From Southwestern Nigeria.

Authors:  Ayorinde O Afolayan; Anderson O Oaikhena; Aaron O Aboderin; Olatunde F Olabisi; Adewale A Amupitan; Oyekola V Abiri; Veronica O Ogunleye; Erkison Ewomazino Odih; Abolaji T Adeyemo; Adeyemi T Adeyemo; Temitope O Obadare; Monica Abrudan; Silvia Argimón; Sophia David; Mihir Kekre; Anthony Underwood; Abiodun Egwuenu; Chikwe Ihekweazu; David M Aanensen; Iruka N Okeke
Journal:  Clin Infect Dis       Date:  2021-12-01       Impact factor: 9.079

7.  Use of Nanopore Sequencing to Characterise the Genomic Architecture of Mobile Genetic Elements Encoding bla CTX-M-15 in Escherichia coli Causing Travellers' Diarrhoea.

Authors:  Matthew T Bird; David R Greig; Satheesh Nair; Claire Jenkins; Gauri Godbole; Saheer E Gharbia
Journal:  Front Microbiol       Date:  2022-03-29       Impact factor: 5.640

8.  Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017-2018).

Authors:  Sirigade Ruekit; Apichai Srijan; Oralak Serichantalergs; Katie R Margulieux; Patrick Mc Gann; Emma G Mills; William C Stribling; Theerasak Pimsawat; Rosarin Kormanee; Suthisak Nakornchai; Chaiwat Sakdinava; Prawet Sukhchat; Mariusz Wojnarski; Samandra T Demons; John M Crawford; Paphavee Lertsethtakarn; Brett E Swierczewski
Journal:  BMC Infect Dis       Date:  2022-08-17       Impact factor: 3.667

9.  Genetic characterization of TEM-type ESBL-associated antibacterial resistance in Enterobacteriaceae in a tertiary hospital in Ghana.

Authors:  Daniel Oduro-Mensah; Noah Obeng-Nkrumah; Evelyn Yayra Bonney; Ebenezer Oduro-Mensah; Kingsley Twum-Danso; Yaa Difie Osei; Sammy Tawiah Sackey
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-05-04       Impact factor: 3.944

10.  Insights and genetic features of extended-spectrum beta-lactamase producing Escherichia coli isolates from two hospitals in Ghana.

Authors:  Samiratu Mahazu; Wakana Sato; Alafate Ayibieke; Isaac Prah; Takaya Hayashi; Toshihiko Suzuki; Shiroh Iwanaga; Anthony Ablordey; Ryoichi Saito
Journal:  Sci Rep       Date:  2022-02-03       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.